Giorgio Giaccone

Author PubWeight™ 51.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol 2013 2.29
2 Conversion of the BASE prion strain into the BSE strain: the origin of BSE? PLoS Pathog 2007 1.97
3 Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol 2008 1.85
4 Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol 2010 1.66
5 Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol 2006 1.56
6 Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium. Acta Neuropathol 2008 1.51
7 Tetracyclines affect prion infectivity. Proc Natl Acad Sci U S A 2002 1.39
8 Brain protein preservation largely depends on the postmortem storage temperature: implications for study of proteins in human neurologic diseases and management of brain banks: a BrainNet Europe Study. J Neuropathol Exp Neurol 2007 1.38
9 Effects of formalin fixation, paraffin embedding, and time of storage on DNA preservation in brain tissue: a BrainNet Europe study. Brain Pathol 2007 1.36
10 Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol 2012 1.29
11 Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol 2009 1.27
12 Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis. Hum Mol Genet 2013 1.23
13 Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol 2009 1.17
14 Inter-laboratory comparison of neuropathological assessments of beta-amyloid protein: a study of the BrainNet Europe consortium. Acta Neuropathol 2008 1.13
15 Current concepts in Alzheimer's disease: a multidisciplinary review. Am J Alzheimers Dis Other Demen 2009 1.12
16 Assessment of alpha-synuclein pathology: a study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol 2008 1.08
17 A new function of microtubule-associated protein tau: involvement in chromosome stability. Cell Cycle 2008 0.98
18 Prion deposition in olfactory biopsy of sporadic Creutzfeldt-Jakob disease. Ann Neurol 2004 0.97
19 A novel Italian presenilin 2 gene mutation with prevalent behavioral phenotype. J Alzheimers Dis 2009 0.96
20 Spinocerebellar ataxia type 17 (SCA17): oculomotor phenotype and clinical characterization of 15 Italian patients. J Neurol 2007 0.92
21 MM2-thalamic Creutzfeldt-Jakob disease: neuropathological, biochemical and transmission studies identify a distinctive prion strain. Brain Pathol 2012 0.90
22 Defective tumor necrosis factor-alpha-dependent control of astrocyte glutamate release in a transgenic mouse model of Alzheimer disease. J Biol Chem 2005 0.88
23 Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody. Neurobiol Dis 2006 0.87
24 APP mutations in the Aβ coding region are associated with abundant cerebral deposition of Aβ38. Acta Neuropathol 2012 0.86
25 Neuropathological and clinical phenotype of an Italian Alzheimer family with M239V mutation of presenilin 2 gene. J Neuropathol Exp Neurol 2004 0.85
26 Role of plasminogen in propagation of scrapie. J Virol 2005 0.85
27 Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP. Arch Neurol 2010 0.85
28 Good gene, bad gene: new APP variant may be both. Prog Neurobiol 2012 0.84
29 Brain delivery of AAV9 expressing an anti-PrP monovalent antibody delays prion disease in mice. Prion 2012 0.84
30 The need to unify neuropathological assessments of vascular alterations in the ageing brain: multicentre survey by the BrainNet Europe consortium. Exp Gerontol 2012 0.84
31 APE1/Ref-1 in Alzheimer's disease: an immunohistochemical study. Neurosci Lett 2009 0.83
32 Myoclonus in Creutzfeldt-Jakob disease: polygraphic and video-electroencephalography assessment of 109 patients. Mov Disord 2010 0.83
33 A novel progranulin mutation causing frontotemporal lobar degeneration with heterogeneous phenotypic expression. J Alzheimers Dis 2011 0.82
34 Neocortical variation of Abeta load in fully expressed, pure Alzheimer's disease. J Alzheimers Dis 2010 0.81
35 Sporadic Creutzfeldt-Jakob disease: the extent of microglia activation is dependent on the biochemical type of PrPSc. J Neuropathol Exp Neurol 2005 0.81
36 The behavioural features of fatal familial insomnia: A new Italian case with pathological verification. Sleep Med 2008 0.81
37 Up-regulation of β-amyloidogenesis in neuron-like human cells by both 24- and 27-hydroxycholesterol: protective effect of N-acetyl-cysteine. Aging Cell 2014 0.81
38 Lewy body pathology and typical Parkinson disease in a patient with a heterozygous (R275W) mutation in the Parkin gene (PARK2). Acta Neuropathol 2012 0.81
39 Panencephalopathic Creutzfeldt-Jakob disease with distinct pattern of prion protein deposition in a patient with D178N mutation and homozygosity for valine at codon 129 of the prion protein Gene. Brain Pathol 2013 0.79
40 A novel pathogenic PSEN1 mutation in a family with Alzheimer's disease: phenotypical and neuropathological features. J Alzheimers Dis 2011 0.78
41 Periodic electroencephalogram complexes in a patient with variant Creutzfeldt-Jakob disease. Ann Neurol 2006 0.78
42 Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium. J Neural Transm (Vienna) 2014 0.78
43 Cognitive deficits in familial Alzheimer's disease associated with M239V mutation of presenilin 2. Dement Geriatr Cogn Disord 2006 0.77
44 The Existence of Primary Age-Related Tauopathy Suggests that not all the Cases with Early Braak Stages of Neurofibrillary Pathology are Alzheimer's Disease. J Alzheimers Dis 2015 0.77
45 The epsilon isoform of 14-3-3 protein is a component of the prion protein amyloid deposits of Gerstmann-Sträussler-Scheinker disease. J Neuropathol Exp Neurol 2007 0.77
46 New mutations in MAPT gene causing frontotemporal lobar degeneration: biochemical and structural characterization. Neurobiol Aging 2011 0.77
47 Familial frontotemporal dementia associated with the novel MAPT mutation T427M. J Neurol 2005 0.77
48 New lexicon and criteria for the diagnosis of Alzheimer's disease. Lancet Neurol 2011 0.77
49 Variability of the clinical phenotype in an Italian family with dementia associated with an intronic deletion in the GRN gene. J Alzheimers Dis 2011 0.76
50 Hereditary and sporadic beta-amyloidoses. Front Biosci (Landmark Ed) 2013 0.75
51 Idiopathic progressive chorea: misnomer or still reality? A case with neuropathological disconfirmation. Neurol Sci 2014 0.75
52 Erratum to: Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium. J Neural Transm (Vienna) 2015 0.75